Fresenius Hid 'Serious' Health Risks Of GranuFlo, Suit Says

Law360, New York (August 27, 2013, 2:14 PM EDT) -- Fresenius USA Inc. was hit with a false advertising suit in California state court Friday by a proposed class claiming the company knowingly concealed the health risks of its dialysis drug GranuFlo dry acid concentrate, including heart attack and stroke.

The plaintiffs, who claim they had received the drug in the course of dialysis treatment since 2000, accuse Fresenius of carrying out a scheme to promote the product despite knowing about its dangerous side effects, including cardiac arrhythmias and other heart ailments.

The company began selling...
To view the full article, register now.